The economic burden of advanced liver disease among patients with Hepatitis C Virus: a large state Medicaid perspective

Table 5 Generalized linear model ¹ predicting adjusted all-cause PPPM healthcare costs

Parameter	Beta-coefficient	Odds ratio	P-Value
Male	0.0508	1.05	0.266
Charlson Score² of 1	0.2977	1.35	<.001
Charlson Score of 2	0.4745	1.61	<.001
Charlson Score ≥3	0.8231	2.28	<.001
Alcoholic Cirrhosis	0.2759	1.32	<.001
Hepatitis B Virus (HBV)	0.3638	1.44	<.001
Age (Continuous Variable)	−0.0048	1.00	0.061
Black	0.1557	1.17	0.007
Hispanic	−0.1095	0.90	0.169
Other Race	0.0869	1.09	0.219
Cases (HCV with ALD)	0.8728	2.39	<.001

Source: Florida Medicaid database: claims with dates of service between July 1, 1998 and June 30, 2008.
Reference groups included: Females, Charlson score 0, patients with no diagnosis of alcoholic cirrhosis or HBV, Whites, and comparison patients (HCV with no ALD).
Model fit statistics: Degrees of freedom (2374), scaled deviance (2842), log-likelihood (61454257).
1 Constructed using a using a log-link function and negative binomial distribution.
² Charlson score excludes HCC, 'Mild Liver Disease' and 'Liver Disease' comorbidities.
PPPM per-patient-per-month.

ISSN: 1472-6963